SR9011 Capsule

Lub ntsiab functional mechanism ntawmSR9011 tsilub hauv paus ntawm kev ua kom REV-ERB / ​​receptors. Raws li pivotal nuclear receptors nyob rau hauv mammalian circadian atherosclerosis regulatory network, REV-ERB / ​​yog dav faib nyob rau hauv lub siab, skeletal leeg, adipose ntaub so ntswg, hlwb thiab lub cev tsis muaj zog, ncaj qha koom nyob rau hauv lub tseem ceeb physiological txheej txheem nrog rau moos gene qhia kev cai, lub zog metabolism sib npaug, inflammatory teb thiab cell proliferation thiab sib txawv. Raws li ib tug muaj zog agonist, CS-2028 tshwj xeeb khi rau REV-ERB / ​​receptors los txhim kho lawv cov kev tawm tsam kev tawm tsam, yog li ua rau muaj ntau yam kev tswj hwm lub cev.

Ntawm ib sab, CS-2028 ncaj qha cuam tshuam qhov kev hloov pauv ntawm cov core moos genes BMAL1 thiab CLOCK, rov pib cuam tshuam circadian rhythms thiab kho cov kab mob lom neeg uas tshwm sim los ntawm kev nyob lig, dav hlau lag thiab lwm yam. Ntawm qhov tod tes, REV-ERB receptor activation upregulates cov kev qhia ntawm mitochondria-hais txog cov noob, boosts mitochondrial kom muaj nuj nqis thiab oxidative ua pa muaj nuj nqi, elevates basal zog noj, thiab modulates cov kev ua ntawm cov enzymes koom nrog hauv qabzib thiab lipid metabolism kom ua tiav ob qho tib si qabzib. Tsis tas li ntawd, CS-2028 inhibits qhov kev qhia ntawm qhov tseem ceeb inflammatory pathway yam tseem ceeb kom alleviate mob o thiab inhibits proliferation voj voog ntawm cov qog nqaij hlav cancer, endowing CS-2028 nrog dav kev tshawb fawb muaj peev xwm nyob rau hauv ntau lub teb.

1. Metabolic Regulation: Fat Poob, Glycemic Control thiab Lipid Modulation

Hauv kev tswj hwm kev noj qab haus huv, CS-2028 siv cov txiaj ntsig tseem ceeb ntawm kev txo cov rog, tswj ntshav qab zib thiab hloov ntshav lipid, suav nrog nws cov haujlwm tseem ceeb tshaj plaws uas tau kawm. Hauv kev sim tsiaj ua rau cov nas rog rog vim yog cov zaub mov muaj roj ntau, kev tswj hwm tas li ntawm CS-2028 rau 2 mus rau 3 lub hlis ua rau lub cev hnyav hnyav nrog cov rog poob ntawm 10 mus rau 15 phaus. CS-2028 feem ntau txo cov roj visceral tsis zoo uas tsis ua rau cov leeg pob txha loj hlob, paub txog cov rog poob thaum khaws cov leeg nqaij.

Nws cov rog-txo qis yog nyob rau hauv kev ua kom REV-ERB receptors los cuam tshuam cov haujlwm ntawm cov enzymes tseem ceeb xws li fatty acid synthase (FAS) thiab stearoyl-CoA desaturase 1 (SCD1), curbing adipocyte synthesis thiab tsub zuj zuj, thiab upregulating mob lipolysis thiab fatty acids - decomposition, uas markedly nce zog siv txawm nyob rau hauv lub xeev so.

Rau kev tswj hwm cov piam thaj hauv cov metabolism, cov khoom lag luam txhim kho insulin rhiab heev, txo qis cov ntshav qabzib sai thiab txo qis insulin tsis kam, nthuav tawm cov txiaj ntsig zoo kawg nkaus ntawm cov ntsuas glycemic hauv hom 2 mob ntshav qab zib hom tsiaj.

Cov kev tshawb fawb cuam tshuam tau lees paub tias CS-2028 tswj cov ntshav qabzib homeostasis los ntawm kev tswj cov kab mob siab glycogen synthesis thiab decomposition, muab cov lus qhia tshiab lub hom phiaj rau kev tshawb fawb txog metabolic. Tsis tas li ntawd, cov qauv no ua kom zoo dua cov ntshav lipid profile, txo cov ntshav triglycerides, tag nrho cov roj cholesterol thiab qis -density lipoprotein (LDL) thaum nce siab -density lipoprotein (HDL), yog li txo qis kev pheej hmoo ntawm cov kab mob plawv xws li atherosclerosis. Qhov tseem ceeb, CS-2028 yog cov tshuaj tsis yog tshuaj hormones. Tsis zoo li ib txwm xaiv androgen receptor modulators (SARMs), CS-2028 tsis cuam tshuam nrog endogenous testosterone secretion, tshem tawm qhov xav tau rau kev kho tom qab lub voj voog (PCT), uas yog qhov sib txawv ntawm cov kev tshawb fawb sib piv.

2. Kev Txhim Kho Kev Ua Haujlwm Zoo: Kev Txhim Kho Kev Txhim Kho Kev Ua Haujlwm thiab Kev Ua Haujlwm Zoo

Txhim kho kev ua kis las, txhawb lub cev kev ua siab ntev thiab ua kom nrawm dua tom qab- qoj ib ce rov qab sawv cev rau lwm qhov tseem ceeb ntawm cov khoom. Ntau qhov kev tshawb fawb tau txheeb xyuas nws cov txiaj ntsig zoo hauv kev txhim kho cov leeg pob txha. Los ntawm kev ua kom REV-ERB receptors, CS-2028 pom tau tias ua rau kom muaj nuj nqis thiab kev ua haujlwm ntawm mitochondria hauv cov leeg pob txha, ntxiv dag zog rau oxidative metabolism muaj peev xwm thiab txhawb nqa cov leeg nqaij oxygen siv efficiency, yog li ua kom lub sijhawm ua haujlwm ntev thiab txo qis qaug zog, ua haujlwm zoo ib yam.

Hauv kev sim tsiaj locomotor, nas siv nrog nws ua tiav ntau dua 30% kev ua haujlwm siab dua piv nrog rau pawg tswj hwm, nrog rau kev txo qis tom qab- qoj ib ce lactic acid tsub zuj zuj, txo cov leeg mob thiab 20% -30% lub sijhawm rov qab luv dua. Cov teebmeem no feem ntau yog los ntawm kev txhim kho mitochondrial muaj nuj nqi. Raws li lub zog cellular powerhouse, activated mitochondria muab ntau lub zog rau cov leeg pob txha thiab txo qis metabolic pov tseg, yog li txhim kho kev ua kis las thiab ua kom lub cev rov qab sai.

Tsis tas li ntawd, CS-2028 modulates cov leeg nqaij lub zog metabolism txoj hauv kev los pab txhawb cov leeg nqaij fiber ntau kho thiab kev loj hlob, ntxiv dag zog rau cov leeg nqaij thiab kev ua siab ntev. Li no, CS-2028 yog dav siv hauv kev tshawb fawb tshawb fawb txog kev tawm dag zog lub cev thiab cov leeg nqaij metabolism. Nws yuav tsum tau hais tias txawm hais tias nws cov khoom ua kis las txhawb nqa kev ua kis las, CS-2028 tsis tau txais kev pom zoo rau tib neeg kev siv tshuaj kho mob thiab ua rau muaj kev phom sij rau kev nyab xeeb, yog li kev siv tsis raug cai los ntawm cov neeg ncaws pob raug txwv nruj.

3. Kev tiv thaiv - Kev Tiv Thaiv Kab Mob thiab Kev Tiv Thaiv Kev Tiv Thaiv: Kev Tiv Thaiv Kab Mob thiab Kev Tiv Thaiv Kev Tiv Thaiv Homeostasis Maintenance

Hais txog kev tiv thaiv -inflammatory thiab immunomodulatory teebmeem,SR9011 tsiua kom muaj zog tiv thaiv -kev ua ub no thiab tswj kev tiv thaiv kab mob los ntawm kev ua haujlwm ntawm REV-ERB receptors. Kev mob ntev ua haujlwm ua haujlwm tseem ceeb rau ntau yam kab mob xws li mob caj dab, rog- cuam tshuam o thiab neuroinflammation, thiab REV-ERB receptors ua lub luag haujlwm tseem ceeb hauv kev kho mob inflammatory teb.

Los ntawm kev ua kom REV-ERB / , CS-2028 txo qis cov kev qhia ntawm pro-cov kab mob sib kis xws li nuclear factor-kappa B (NF-κB), interleukin-6 (IL-6) thiab qog necrosisalpha (1) thiab TN4} tshuaj tiv thaiv kab mob (t. cytokines zoo li interleukin-10 (IL-10), zoo alleviating mob inflammatory mob. Hauv kev sim hauv vitro microglia, CS-2028 ua rau muaj kev cuam tshuam rau cov kab mob cytokine pro-inflammatory, inhibits mitochondrial respiration thiab ATP ntau lawm, thiab tsis muaj zog phagocytic kev ua si, qhia txog nws lub luag haujlwm tseem ceeb hauv kev sib tham ntawm cerebral metabolism thiab kev tiv thaiv kab mob.

Ntxiv mus, qhov kev tsim no sib npaug qhov sib txawv ntawm Treg / Th17 hlwb kom txo tau cov lus teb autoimmune, muab cov kev tshawb fawb tshiab rau cov kab mob autoimmune xws li mob caj dab thiab kab mob lupus erythematosus, thiab xav tias yuav nthuav tawm cov hom phiaj kho mob tshiab rau cov mob no.

4. Anti-Tumor Potential: Targeted Inhibition of Cancer Cell Proliferation

Cov khoom lag luam kuj tseem muaj kev cog lus los tiv thaiv- cov kev tshawb fawb qog nqaij hlav, uas feem ntau pom tau los ntawm kev txwv tsis pub qog nqaij hlav qog noj ntshav thiab ua rau mob qog noj ntshav apoptosis kom ua tiav cov phiaj xwm qog nqaij hlav.

Kev tshawb fawb pom tau tias CS-2028 qhib REV-ERB receptors los inhibit cyclin A qhia, thaiv kev hloov pauv ntawm cov qog nqaij hlav cancer los ntawm G0/G1 theem mus rau theem S thiab G2/M theem thiab ntes cov qog nqaij hlav cancer ntawm theem G0/G1 kom nres lawv cov kev loj hlob thiab kev faib tawm.

Qhov tseem ceeb tshaj, CS-2028 nthuav tawm cov kev xaiv cytotoxicity tawm tsam cov qog nqaij hlav qog noj ntshav nyob ntawm de novo lipogenesis, suav nrog mob qog noj ntshav mis, mob qog noj ntshav thiab lub ntsws qog nqaij hlav, thaum ua rau muaj kev cuam tshuam me me rau cov hlwb ib txwm, ua CS-2028 yog ib qho kev tshawb fawb zoo tshaj plaws rau kev tshawb nrhiav qog nqaij hlav. Tsis tas li ntawd, CS-2028 inhibits qog angiogenesis thiab txo cov inflammatory yam nyob rau hauv cov qog microenvironment ntxiv mus cuam tshuam cov qog metastasis thiab ntxeem tau.

Hauv kev sim hauv vivo qog cov qauv, kev tswj hwm qhov ncauj ntawm cov khoom lag luam zoo kawg nkaus txo qis qhov tshwm sim ntawm cov qog nqaij hlav thiab txo qis cov qog nqaij hlav, tso cov kev sim hauv paus rau kev tsim kho tshiab los tiv thaiv-cov tswv yim kho mob qog noj ntshav.

5. Neuroprotection thiab Circadian Rhythm Regulation

Cov khoom lag luam kuj tseem cuam tshuam qhov tseem ceeb ntawm kev tiv thaiv neuroprotection thiab circadian atherosclerosis. Tshaj tawm thoob plaws hauv cov ntaub so ntswg hauv hlwb, REV-ERB receptors koom nrog kev hloov pauv ntawm circadian rhythms, pw tsaug zog zoo thiab ua haujlwm ntawm lub paj hlwb.

CS-2028 rov pib dua qhov txawv txav ntawm circadian rhythms los txhim kho kev pw tsaug zog tsis zoo tshwm sim los ntawm lub dav hlau lag thiab kev pw tsaug zog tsis zoo, ua kom lub moos lom neeg ruaj khov thiab rov ua haujlwm txhua hnub.

Lub caij no, CS-2028 muab cov txiaj ntsig zoo tiv thaiv kab mob los ntawm kev txo qis neuroinflammation thiab txo qis beta-amyloid protein deposition los txo cov kev puas hlwb neuronal, qhib kev tshawb fawb tshiab rau cov kab mob neurodegenerative xws li Alzheimer's disease. Tsis tas li ntawd, kev tshawb fawb tsiaj ua pov thawj tias CS-2028 tuaj yeem txhim kho lub cev muaj zog thiab lub cev muaj peev xwm hauv cov neeg laus thiab txuas ntxiv kev noj qab haus huv (hais txog kev noj qab haus huv tsis muaj kab mob ntau dua li tag nrho lub neej), muab cov cuab yeej tshawb fawb tseem ceeb rau kev tshawb fawb txog kev laus.